“He Yuan Li Ji” was established as a joint venture between He Yuan Bio (stock code: 688238) and Li Ji Bio, with its core business centered on the “Li Ji Bio” and “Life-ilab” reagent brands.

Select language:

中文

English

HeYuan Li Ji transfection reagent has published 189 papers, with an average IF exceeding 10 and a cumulative IF surpassing 2,000!

Publication date:2024-09-14
Page views:

According to incomplete statistics, as of July 2024, the number of publications across the web that have cited Li Ji Bio®’s transfection product series has reached 189 articles , IF average Value 10.58201 , IF value accumulation Over 2,000+ !

We sincerely thank you all for your support and trust in Heyuan Li Ji. To further advance Chinese scientific research and help you achieve successful experiments, Heyuan Li Ji will continue to refine and upgrade our products while developing new offerings.

Li Ji Bio®’s transfection series has consistently received high praise ( ▔, ▔ )ㄏ

View the official website feedback form: https://life-ilab.com/resource/list-564.html

To date, a total of seven products have been launched. AC04L052-EZ Trans siRNA transfection reagent, AC04L062-EZ Trans mRNA transfection reagent After more than six months of testing and optimization, it has recently gone live and is now available to all of you \(^o^)/! Our annual publication output continues to grow steadily, with 2024 on track to surpass 100 papers. Below is a chart showing the growth trend of publications using Li Ji Bio’s transfection reagents:

According to statistical analysis, the distribution of publications using Li Ji Bio® transfection reagents is shown in the figure below, with articles scoring 10 points or higher accounting for the largest share—totaling 109 papers! There are as many as five articles with scores of 40 or above. 。

The journal CELL has published as many as three full-length articles, one of which appeared on the cover. The highest‑impact article is “Large-Scale Multiplexed Mosaic CRISPR Perturbation in the Whole Organism” (IF: 66.85), with ShanghaiTech University listed as the first author’s affiliation.

%{tishi_zhanwei}%